| Name | Title | Contact Details |
|---|
Destination Imagination, Inc. is an extraordinary non-profit organization that provides educational programs for students to learn and experience creativity, teamwork and problem solving. Every year, we reach 100,000 students across the U.S. and in mor...
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Secure Code Warrior helps developers write more secure code. We are focused on bringing an innovative approach to developer security training. Contact us today.
We’re here to provide smiles worldwide, for you and everyone you love. Because at Recharge.com we make sure you stay in touch with your loved ones, no matter where in the world you are or what time it is. Here you can refill your own or someone elses ...
Welcome to LANDESK`s home on LinkedIn! Follow us for regular tips on systems lifecycle management, endpoint security, and IT service management solutions for desktops, servers and mobile devices. Founded in 1985, LANDESK Software is the only company with proven solutions in the 4 Gartner Magic Quadrants that compose End-to-End Service Management: IT Service Desk, PC Lifecycle Configuration Management, Endpoint Protection, and Mobile Management Platforms.